Literature DB >> 30736983

Patterns of Genomic Instability in Breast Cancer.

Murugan Kalimutho1, Katia Nones2, Sriganesh Srihari3, Pascal H G Duijf4, Nicola Waddell2, Kum Kum Khanna5.   

Abstract

Breast cancer is one of the most common cancers affecting women. Despite significant improvements in overall survival, it remains a significant cause of death worldwide. Genomic instability (GI) is a hallmark of cancer and plays a pivotal role in breast cancer development and progression. In the past decade, high-throughput technologies have provided a wealth of information that has facilitated the identification of a diverse repertoire of mutated genes and mutational processes operative across cancers. Here, we review recent findings on genomic alterations and mutational processes in breast cancer pathogenesis. Most importantly, we summarize the clinical challenges and opportunities to utilize omics-based signatures for better management of breast cancer patients and treatment decision-making.
Copyright © 2019 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  breast cancer; genomic instability; mutation signatures

Mesh:

Year:  2019        PMID: 30736983     DOI: 10.1016/j.tips.2019.01.005

Source DB:  PubMed          Journal:  Trends Pharmacol Sci        ISSN: 0165-6147            Impact factor:   14.819


  26 in total

1.  The miR-345-3p/PPP2CA signaling axis promotes proliferation and invasion of breast cancer cells.

Authors:  Qian Zeng; Fangfang Jin; Husun Qian; Hongling Chen; Yange Wang; Dian Zhang; Yu Wei; Tingmei Chen; Bianqin Guo; Chengsen Chai
Journal:  Carcinogenesis       Date:  2022-03-24       Impact factor: 4.741

2.  Molecular Cytogenomic Characterization of the Murine Breast Cancer Cell Lines C-127I, EMT6/P and TA3 Hauschka.

Authors:  Shaymaa Azawi; Thomas Liehr; Martina Rincic; Mattia Manferrari
Journal:  Int J Mol Sci       Date:  2020-07-01       Impact factor: 5.923

Review 3.  Recent advances of therapeutic targets based on the molecular signature in breast cancer: genetic mutations and implications for current treatment paradigms.

Authors:  Zeinab Safarpour Lima; Mostafa Ghadamzadeh; Farzad Tahmasebi Arashloo; Ghazaleh Amjad; Mohammad Reza Ebadi; Ladan Younesi
Journal:  J Hematol Oncol       Date:  2019-04-11       Impact factor: 17.388

Review 4.  Advances and perspectives of PARP inhibitors.

Authors:  Ming Yi; Bing Dong; Shuang Qin; Qian Chu; Kongming Wu; Suxia Luo
Journal:  Exp Hematol Oncol       Date:  2019-11-11

5.  Rtt105 promotes high-fidelity DNA replication and repair by regulating the single-stranded DNA-binding factor RPA.

Authors:  Xuejie Wang; Yang Dong; Xiaocong Zhao; Jinbao Li; Jordan Lee; Zhenxin Yan; Shuangshuang Yang; Wenqiang Wu; Ximiao Hou; Guangxue Liu; Yueyue Zhang; Lun Song; Gang Cai; Qing Li; Grzegorz Ira; Xinghua Zhang; Xuefeng Chen
Journal:  Proc Natl Acad Sci U S A       Date:  2021-06-22       Impact factor: 11.205

6.  CX-5461 Enhances the Efficacy of APR-246 via Induction of DNA Damage and Replication Stress in Triple-Negative Breast Cancer.

Authors:  Ashwini Makhale; Devathri Nanayakkara; Prahlad Raninga; Kum Kum Khanna; Murugan Kalimutho
Journal:  Int J Mol Sci       Date:  2021-05-28       Impact factor: 5.923

7.  Complexities of pharmacogenomic interactions in cancer.

Authors:  Kum Kum Khanna; Pascal H G Duijf
Journal:  Mol Cell Oncol       Date:  2020-03-19

8.  Computational Detection of Breast Cancer Invasiveness with DNA Methylation Biomarkers.

Authors:  Chunyu Wang; Ning Zhao; Linlin Yuan; Xiaoyan Liu
Journal:  Cells       Date:  2020-01-30       Impact factor: 6.600

9.  Autophagy-associated circRNA circCDYL augments autophagy and promotes breast cancer progression.

Authors:  Gehao Liang; Yun Ling; Maryam Mehrpour; Phei Er Saw; Zihao Liu; Weige Tan; Zhenluan Tian; Wenjing Zhong; Wanyi Lin; Qing Luo; Qun Lin; Qiufang Li; You Zhou; Ahmed Hamai; Patrice Codogno; Jun Li; Erwei Song; Chang Gong
Journal:  Mol Cancer       Date:  2020-03-25       Impact factor: 27.401

10.  Hsa_circ_002178 Promotes the Growth and Migration of Breast Cancer Cells and Maintains Cancer Stem-like Cell Properties Through Regulating miR-1258/KDM7A Axis.

Authors:  Wangyong Li; Xiaoyan Yang; Chengfei Shi; Zhengbo Zhou
Journal:  Cell Transplant       Date:  2020 Jan-Dec       Impact factor: 4.064

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.